Campylobacter concisus: a new character in the Crohn's disease story?
Guslandi
Mario
M
Zhang
Li
L
Man
Si Ming
SM
Day
Andrew S
AS
Leach
Steven T
ST
Lemberg
Daniel A
DA
Dutt
Shoma
S
Stormon
Michael
M
Otley
Anthony
A
O'Loughlin
Edward V
EV
Magoffin
Annabel
A
Ng
Patrick H Y
PH
Mitchell
Hazel
H
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002167:Campylobacter / Q000302:isolation & purification*; D002169:Campylobacter Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology*; D002648:Child; D002986:Clinical Trials as Topic; D003424:Crohn Disease / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology*; D006801:Humans; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin
D000900:Anti-Bacterial Agents; D012294:Rifamycins; D000078262:Rifaximin